Thioridazine hydrochloride

CAS No. 130-61-0

Thioridazine hydrochloride( Aldazine | Mellaril )

Catalog No. M11223 CAS No. 130-61-0

Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 32 In Stock
100MG 43 In Stock
200MG 53 In Stock
500MG 73 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thioridazine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.
  • Description
    Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.(In Vitro):Thioridazine (0.01-100 μM; 48 h) reduces the cell viability of NCI-N87 and AGS cells in a concentration-dependent manner.Thioridazine (15 μM; 24 h) reduces cell viability of the cervical (HeLa, Caski and C33A) and endometrial (HEC-1-A and KLE) cancer cells.Thioridazine (1-15 μM; 24-48 h) induces gastric cancer cell death via the mitochondrial apoptosis pathway and mitochondrial pathway.Thioridazine (15 μM; 24 h) modulates the regulation of cell cycle progression by interfering with the PI3K/Akt pathway and induces G1 cell cycle arrest in cervical and endometrial cancer cells .Thioridazine inhibits the growth of antibiotic-sensitive and multidrug-resistant strains of A. baumannii.(In Vivo):Thioridazine (25 mg/kg; i.p. every 3 days for 3 weeks) extends the survival of tumor-bearing mice and reduces the number of pluripotent embryonal carcinoma (EC) cells within tumors.Thioridazine (1.0-5.0 mg/kg; s.c.) reduces oral behavior and selectively blocks repetitive head bobbing.
  • In Vitro
    Cell Proliferation Assay Cell Line:NCI-N87 and AGS cells Concentration:0.01, 0.1, 0.5, 1, 5, 10, 20, 50, 100 μM.Incubation Time:48 hours Result:Exhibited cytotoxicity in gastric cancer cells.Western Blot Analysis Cell Line:NCI-N87 and AGS cells Concentration:1, 5, 10, 15 μM Incubation Time:24, 48 hours Result:Down regulated the precursors of caspase-9, caspase-8 and caspase-3.
  • In Vivo
    Animal Model:Nude and Rag2KO mice were injected with iPS cells or NT2D1 cells Dosage:25 mg/kg Administration:I.p. every 3 days for 3 weeks Result:Reduced the number of OCT4-expressing cells within malignant teratocarcinomas and extended the survival of tumor-bearing mice.With no effect on fertility.
  • Synonyms
    Aldazine | Mellaril
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT| Adrenergic Receptor| Dopamine| Potassium Channel
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    130-61-0
  • Formula Weight
    407.04
  • Molecular Formula
    C21H27ClN2S2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    Cl.CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Assie MB, et al. Eur J Pharmacol. 1993 Jun 24;237(2-3):183-9.
molnova catalog
related products
  • CTEP

    CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, shows >1000-fold selectivity over other mGlu receptors.

  • Peptide 401

    Peptide 401 is an antimicrobial peptide (AMP) derived from the venom of bees and wasps. Peptide 401 induces mast cell degranulation, activating histamine release from peritoneal mast cells. Additionally, peptide 401 exhibits some anti-inflammatory activity, decreasing paw edema in animal models.

  • L-Stepholidine

    L-Stepholidine (Stepholidine) exhibits mixed dopamine D1 receptor agonist and D2 antagonist properties. L-Stepholidine has neuroprotective effect and inhibits Heroin-induced reinstatement. L-Stepholidine is a potential medication for the research of opiate addiction.